Could 5 days of radiation replace 25 for sarcoma patients?
NCT ID NCT07615049
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a short course of radiation therapy (5 days) to the standard longer course (25 days) for people with soft tissue sarcoma in the arms or legs that can be removed with surgery. The goal is to see if the shorter treatment is just as effective at preventing the cancer from coming back, while being more convenient. About 296 participants will be randomly assigned to one of the two radiation schedules before their surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy
What this could lead to
If this shorter radiation course works, it could become a new standard that saves patients weeks of daily hospital visits without increasing the risk of the cancer coming back.
What could go wrong
This is an early-stage comparison, and the shorter course might not control the tumor as well as the longer one. There is also a risk of more severe side effects from the higher daily radiation doses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE II SOFT TISSUE SARCOMA OF THE TRUNK AND EXTREMITIES AJCC V8 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.